1. Market Research
  2. > Biotechnology
  3. > Genetically Modified Organism Market Trends

EpiCast Report: Duchenne Muscular Dystrophy - Epidemiology Forecast to 2023

  • March 2015
  • 58 pages
  • GlobalData
Report ID: 2869163

Summary

Table of Contents

Search Inside

EpiCast Report: Duchenne Muscular Dystrophy - Epidemiology Forecast to 2023

Summary

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are rare progressive muscle wasting disorders.

GlobalData epidemiologists forecast that the diagnosed prevalent cases of DMD (all ages) in the 6MM will increase from 17,675 diagnosed prevalent cases in 2013 to 17,712 diagnosed prevalent cases in 2023, at an Annual Growth Rate (AGR) of 0.02%. The 6MM had an estimated 6,076 diagnosed prevalent cases of DMD for ages 5-13 years in 2013, and the number of diagnosed prevalent cases is expected to increase to 6,250 by 2023, at an AGR of 0.29%. GlobalData epidemiologists forecast that the diagnosed prevalent cases of DMD with nonsense mutations (all ages) in the 6MM will increase from 2,260 diagnosed prevalent cases in 2013 to 2,264 diagnosed prevalent cases in 2023, at an AGR of 0.02%.

GlobalData epidemiologists used the best available data from peer-reviewed journal articles and national DMD mutation databases to arrive at a meaningful and in-depth analysis of the diagnosed prevalent cases of DMD and BMD for men in the 6MM based on: a confirmed deletion, duplication, or point mutation in the DMD gene; reduced or absent dystrophin immunolabeling; or cases fulfilling “definite” or “probable” criteria of the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet). For all the 6MM, the diagnosed prevalent cases of DMD and BMD were segmented by age, which facilitates an understanding of the distribution of the disease within the population, and informs strategies to improve the management of the disease. The diagnosed prevalent cases of DMD in each of the 6MM were further segmented by therapeutically significant populations including the applicability of exon skipping therapies (exons 51, 45, 53, and 44), nonsense mutations, and cases ages 5-13 years in these markets.

Scope

- The Duchenne Muscular Dystrophy (DMD) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for DMD in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of DMD and Becker Muscular Dystrophy (BMD) in men, segmented by age (in 10-year age groups beginning at 0 years and ending at =40 years for cases of DMD with a special focus on the subgroup of ages 5-13 years, and in 15-year age groups beginning at 0 years and ending at =75 years for cases of BMD) in these markets. Additionally, the diagnosed prevalent cases of DMD (all ages) are further segmented by the applicability of exon skipping therapies (exons 51, 45, 53, and 44) and nonsense mutations.
- The DMD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global DMD market.
- Quantify patient populations in the global DMD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for DMD therapeutics in each of the markets covered.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Digital PCR and Real-time PCR Market by Technology, Product, Application, End User - Forecast to 2022

  • $ 5650
  • Industry report
  • June 2017
  • by MarketsandMarkets

“The global digital PCR and real-time (qPCR) market projected to grow at a CAGR of 8.9%.” The global dPCR and qPCR market is estimated to grow at a CAGR of 8.9% from 2017 to 2022, to reach USD 5.31 ...

Competent Cells Market by Type, Application, End User - Global Forecast to 2022

  • $ 5650
  • Industry report
  • July 2017
  • by MarketsandMarkets

The global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2% Advancements in molecular cloning research due to the emergence of new ...

Global Genetically Modified Seeds Market

  • $ 4850
  • Industry report
  • May 2017
  • by Lucintel

The future of the global genetically modified seed market looks promising with opportunities in the corn, soybean, cotton, and canola segments. The global genetically modified seed market is expected to ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.